Home / business / Bharat Biotech Expects Peer Review of Covaxin's Phase 3 Trials Data in Q4 2021

Bharat Biotech Expects Peer Review of Covaxin's Phase 3 Trials Data in Q4 2021

-
Bharat Biotech said there were nine publications on Covaxin so far and the efficacy paper of phase-3 trials would be the tenth one.

from Top Business News- News18.com
Read The Rest:timesnownews...
Bharat Biotech Expects Peer Review of Covaxin's Phase 3 Trials Data in Q4 2021 Bharat Biotech Expects Peer Review of Covaxin's Phase 3 Trials Data in Q4 2021 Reviewed by Team Exprssnews on June 09, 2021 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.